the active ingredient in Ozempic, from its shortage list. The FDA allows for the sale of compounded versions of drugs on its shortage list to limit patient supply issues. In 2022, the FDA placed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback